If it feels like your insurance premium goes up every single year no matter what, you're not imagining it — and the same is true for a lot of prescription medications. Here's why both of those trends keep happening, and why more people are looking at direct, cash-pay telehealth as a way around some of it.
Why do insurance premiums keep rising?
Health insurance premiums are priced to cover the total cost of care across everyone in a plan, and that underlying cost has been climbing for years — driven by rising hospital and specialist prices, more expensive new treatments and medications entering the market, and overall medical inflation that routinely outpaces general inflation. Employer-sponsored family premiums have, on average, roughly doubled over the past decade and a half. Even when your employer absorbs part of that increase, it shows up elsewhere — in a higher deductible, a higher copay, or a smaller raise.
Why do prescription drugs cost so much in the first place?
A few things compound here. Brand-name drugs, especially newer ones still under patent, are priced with no generic competition to push the price down. Pricing in the U.S. also works differently than in most other countries, where governments negotiate drug prices directly — in the U.S., list prices are set largely by manufacturers, then negotiated down (sometimes significantly) behind the scenes by insurers and pharmacy benefit managers, with the actual out-of-pocket result for any one patient depending heavily on their specific plan. That's part of why the same medication can cost wildly different amounts for two people with two different insurance plans — or none at all.
So how does cash-pay telehealth change the equation?
A cash-pay model skips the insurance negotiation layer entirely: the doctor's visit and the medication are priced directly and shown to you up front, before you commit. For many common generic medications — the kind used to treat chronic conditions like high blood pressure, high cholesterol, and type 2 diabetes — that direct price can be lower than what someone with a high deductible or a thin formulary ends up paying out of pocket through insurance, especially earlier in the year before a deductible is met.
This doesn't mean cash-pay is always cheaper than insurance — if you have a low-deductible plan with good drug coverage, your copay may well beat a cash price. But for the growing number of people with high- deductible plans, thin coverage, or no insurance at all, a transparent, flat, direct price removes the guesswork of "what will this actually cost me," which is often the more frustrating part of the current system than the price itself.
The bottom line
Both insurance premiums and drug prices are trending in the same direction — up — for structural reasons that aren't changing soon. Knowing the exact price of a visit and a medication before you commit to either one is one of the few ways to actually get ahead of that trend instead of finding out the cost after the fact.